9 completed, 2 terminated. 11 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Completed 9, Terminated 2 |
Follow Baraclude: new trials by email Literature Review of Baraclude trials Research Report on Baraclude
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors Best Practice, Entecavir, Tenofovir Alafenamide - Hepatitis B Infection, Malignant Solid Neoplasm | Phase 3 | Terminated | SWOG Cancer Research Network | 4 | 2020-01-17 | 2024-05-20 |
| Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B Telbivudine, Entecavir - Chronic Viral Hepatitis B Without Delta-agent | Phase 3 | Completed | Asan Medical Center | 98 | 2012-05-01 | 2017-01-26 |
| A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus Infection Entecavir, Placebo - Chronic Hepatitis B Virus, Pediatric | Phase 3 | Completed | Bristol-Myers Squibb | 180 | 2010-06-30 | 2019-05-09 |
| A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B Infection Entecavir + Tenofovir, Adefovir + continuing Lamivudine - Chronic Hepatitis B | Phase 3 | Terminated | Bristol-Myers Squibb | 4 | 2008-08-01 | 2010-11-23 |
| Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir Entecavir - Liver Transplantation, Hepatitis B | Phase 3 | Completed | HepNet Study House, German Liverfoundation | 20 | 2008-03-01 | 2014-11-05 |
| Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus Entecavir, Tenofovir, Adefovir - Hepatitis B, Chronic | Phase 3 | Completed | Bristol-Myers Squibb | 629 | 2008-03-01 | 2013-11-21 |
| Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B Entecavir, Entecavir + Tenofovir - Hepatitis B, Chronic | Phase 3 | Completed | Bristol-Myers Squibb | 669 | 2007-04-01 | 2013-03-15 |
| Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection entecavir - Hepatitis B, Chronic | Phase 3 | Completed | Bristol-Myers Squibb | 109 | 2007-04-01 | 2012-05-31 |
| Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection entecavir, adefovir - Hepatitis B, Chronic Disease | Phase 3 | Completed | Bristol-Myers Squibb | 69 | 2004-12-01 | 2010-08-10 |
| Continue Entecavir Rollover From China Entecavir - Chronic Hepatitis B Virus | Phase 3 | Completed | Bristol-Myers Squibb | 600 | 2004-05-01 | 2010-02-02 |
| Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation Entecavir (ETV), Adefovir (ADV) - Hepatitis B | Phase 3 | Completed | Bristol-Myers Squibb | 195 | 2003-08-01 | 2013-06-24 |
Hepatitis B, Chronic (7) · Hepatitis B (4) · Chronic Disease (1) · Liver Diseases (1)
Bristol-Myers Squibb (8) · Asan Medical Center (1) · HepNet Study House, German Liverfoundation (1) · SWOG Cancer Research Network (1)
United States (8) · Canada (5) · Poland (5) · Taiwan (5) · Brazil (4) · India (4) · Italy (4) · Russia (4) · South Korea (4) · Turkey (Türkiye) (4) · Argentina (3) · Australia (3) · France (3) · Germany (3) · Greece (3)
Heiner Wedemeyer, MD (1) · Jessica P Hwang (1) · Michael P Manns, MD (1) · Young-Suk Lim, M.D., Ph.D. (1)
PMID 22643350, PMID 26223345, PMID 28103819
2008 (1), UG1CA189974 (1)